News
Gaming and Leisure Properties, Inc. (NASDAQ:GLPI) is one of the most undervalued stocks. On June 5, Stifel analysts ...
Equity Residential (NYSE:EQR) is one of the most undervalued stocks. On June 5, Stifel maintained a Buy rating on EQR with a ...
Vistagen Therapeutics, Inc. (NASDAQ:VTGN) is among the best growth stocks to invest in for the next 5 years. Analysts at ...
Financial services provider Stifel (NYSE:SF) announced on Thursday an increase in its May-end client assets, and estimated ...
Oracle (ORCL) shares rose more than 6% on Monday after CEO Safra Catz touted a "strong start" to fiscal 2026 and investment ...
According to Benzinga Pro, Stifel Financial's peer group average for short interest as a percentage of float is 3.25%, which ...
Detailed price information for Arizona Metals Corp (AZMCF) from The Globe and Mail including charting and trades.
The $1.5 billion settlement in 2003 and 2004 addressed a scandal over analysts issuing positive research to help Citigroup, ...
View the latest Stifel Financial Corp. 5.2% Sr. Notes due 2047 (SFB) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Stifel co-president Nesi to retire, join board as Institutional Group revenue soars under his tenure
One of the financial services company's top investment bankers is retiring after 16 years, but he'll still have a role with ...
Analysts at Stifel reiterated their Buy rating on Vistagen Therapeutics, Inc. (NASDAQ:VTGN) with an unchanged price target of $12.00 post the company’s fiscal 2025 announcement.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results